BIIB BIOGEN INC Earnings Reports 8-K Filing 2025 - Earnings Loss Biogen Inc reported a quarterly earnings loss of $1.4 billion, primarily due to a decline in sales of its Alzheimer's drug, Aduhelm, and ongoing costs related to research and development.Get access to all SEC 8-K filings of the BIOGEN INC